Bluejay diagnostics, inc.BJDX.US Overview
BJDX Overall Performance
BJDX AI Analysis & Strategy
BJDX Recent Performance
-0.25%
Bluejay diagnostics, inc.
0.81%
Avg of Sector
-1.14%
S&P500
BJDX PowerScanner
BJDX Key Information
BJDX Valuation Metrics
BJDX Earnings Table
BJDX Profile
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.